Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.74	71.34	88.4	53.64	96.45	65.08
Short-Term Investments	118.08	156.62	183.46	355.95	290.61	219.36
Cash & Short-Term Investments	190.82	227.96	271.86	409.59	387.06	284.44
Cash Growth	-47.35%	-16.15%	-33.63%	5.82%	36.08%	180.89%
Accounts Receivable	106.69	73.07	25.81	8.46	-	-
Other Receivables	-	-	-	-	-	0.51
Receivables	106.69	73.07	25.81	8.46	-	0.51
Inventory	16.32	14.53	13.13	7.51	-	-
Prepaid Expenses	8.68	12.29	10.1	7.39	14.17	6.33
Restricted Cash	0.31	0.62	0.93	1.23	1.54	1.54
Other Current Assets	9.96	7.37	8.61	3.23	-	-
Total Current Assets	332.78	335.82	330.43	437.41	402.77	292.83
Property, Plant & Equipment	3.12	2.99	3.9	4.6	5.3	5.37
Other Intangible Assets	15.94	9.48	6.44	7.19	-	-
Other Long-Term Assets	0.6	0.6	0.6	0.08	0.08	0.08
Total Assets	352.43	348.89	341.37	449.27	408.15	298.27
Accounts Payable	15.08	14.22	11.99	8.83	7.35	7.14
Accrued Expenses	87.85	65.97	33.94	28.32	25.54	15.29
Current Portion of Leases	-	0.82	0.74	0.66	0.43	-
Other Current Liabilities	-	-	-	-	-	0.18
Total Current Liabilities	103.94	81.01	46.67	37.81	33.33	22.6
Long-Term Debt	107.05	107.2	201.8	197.77	72.35	-
Long-Term Leases	2.11	2.56	3.38	4.12	4.77	4.96
Other Long-Term Liabilities	0.36	0.57	0.85	-	0.03	0.08
Total Liabilities	213.46	191.35	252.7	239.69	110.48	27.65
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,302	1,279	1,071	930.43	706.23	472.57
Retained Earnings	-1,163	-1,122	-981.9	-719.76	-408.31	-201.95
Comprehensive Income & Other	-0.04	-0.01	0	-1.09	-0.26	-0
Total Common Equity	138.97	157.54	88.67	209.58	297.68	270.62
Shareholders' Equity	138.97	157.54	88.67	209.58	297.68	270.62
Total Liabilities & Equity	352.43	348.89	341.37	449.27	408.15	298.27
Total Debt	110.16	110.59	205.92	202.54	77.56	4.96
Net Cash (Debt)	80.66	117.37	65.95	207.05	309.5	279.48
Net Cash Growth	-47.92%	77.98%	-68.15%	-33.10%	10.74%	176.83%
Net Cash Per Share	0.64	0.97	0.95	3.76	6.26	7.84
Filing Date Shares Outstanding	119.91	118.64	96.81	61.08	50.38	50.08
Total Common Shares Outstanding	119.8	117.85	96.79	61.04	50.26	43.34
Working Capital	228.84	254.81	283.76	399.6	369.45	270.22
Book Value Per Share	1.16	1.34	0.92	3.43	5.92	6.24
Tangible Book Value	123.04	148.06	82.23	202.39	297.68	270.62
Tangible Book Value Per Share	1.03	1.26	0.85	3.32	5.92	6.24
Machinery	-	1.93	1.79	1.36	1.12	0.52
Construction In Progress	-	-	-	-	-	0.3
Leasehold Improvements	-	1.57	1.57	1.57	1.57	1.28

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q